Lewis b

General | Antibody | Glycoprotein | Glycolipid | Enzyme | Reference

14 reference for EP0010

sort by year Reference detail
1 Creuzot-Garcher C, Guerzider V, Assem M, Bron AM, Delannoy P, Bara J.
Alteration of sialyl Lewis epitope expression in pterygium.
Invest Ophthalmol Vis Sci. 1999 Jul ;40(8):1631-6
PMID: 10393028
2 Brockhaus M, Magnani JL, Blaszczyk M, Steplewski Z, Koprowski H, Karlsson KA, Larson G, Ginsburg V.
Monoclonal antibodies directed against the human Leb blood group antigen.
J Biol Chem. 1981 Dec 25;256(24):13223-5
PMID: 7309759
3 Torrado J, Correa P, Ruiz B, Bernardi P, Zavala D, Bara J.
Lewis antigen alterations in gastric cancer precursors.
Gastroenterology. 1992 Feb ;102(2):424-30
PMID: 1732113
4 Bara J, Gautier R, Le Pendu J, Oriol R.
Immunochemical characterization of mucins. Polypeptide (M1) and polysaccharide (A and Leb) antigens.
Biochem J. 1988 Aug 15;254(1):185-93
PMID: 2460087
5 Good AH, Yau O, Lamontagne LR, Oriol R.
Serological and chemical specificities of twelve monoclonal anti-Lea and anti-Leb antibodies.
Vox Sang. 1992 ;62(3):180-9
PMID: 1609521
6 Torrado J, Correa P, Ruiz B, Zavala D, Bara J.
Prospective study of Lewis antigen alterations in the gastric precancerous process.
Cancer Epidemiol Biomarkers Prev. 1992 Mar ;1(3):199-205
PMID: 1306106
7 Sakamoto J, Furukawa K, Cordon-Cardo C, Yin BW, Rettig WJ, Oettgen HF, Old LJ, Lloyd KO.
Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines.
Cancer Res. 1986 Mar ;46(3):1553-61
PMID: 3510728
8 Yazawa S, Akamatsu S, Tachikawa T, Naito H, Nakamura J, Asao T, Nagamachi Y, Nakajima T, Shin S, Chia D.
Development and characterization of a novel anti-fucosylated antigen monoclonal antibody YB-2 and its usefulness in the immunohistochemical diagnosis of colorectal cancer.
Jpn J Cancer Res. 1993 Jun ;84(6):641-8
PMID: 8340252
9 Naitoh H, Yazawa S, Asao T, Nakajima T, Nakamura J, Takenoshita S, Nagamachi Y.
The recognition of cancer-associated fucosylated antigens in colorectal cancer by a novel monoclonal antibody, YB-2.
Surg Today. 1994 ;24(4):382-4
PMID: 8038519
10 Yazawa S, Nishimura T, Ide M, Asao T, Okamura A, Tanaka S, Takai I, Yagihashi Y, Saniabadi AR, Kochibe N.
Tumor-related expression of alpha1,2fucosylated antigens on colorectal carcinoma cells and its suppression by cell-mediated priming using sugar acceptors for alpha1,2fucosyltransferase.
Glycobiology. 2002 Sep ;12(9):545-53
PMID: 12213787
11 Nakamura J, Yazawa S, Hada T, Asao T, Naitoh H, Takenoshita S, Kosaka M, Akamatsu S, Tachikawa T, Nagamachi Y.
The usefulness of anti-fucosylated antigen antibody YB-2 for diagnosis of hepatocellular carcinoma.
Glycoconj J. 1997 Jan ;14(1):81-7
PMID: 9076517
12 Cordon-Cardo C, Lloyd KO, Sakamoto J, McGroarty ME, Old LJ, Melamed MR.
Immunohistologic expression of blood-group antigens in normal human gastrointestinal tract and colonic carcinoma.
Int J Cancer. 1986 May 15;37(5):667-76
PMID: 3516890
13 Cordon-Cardo C, Lloyd KO, Finstad CL, McGroarty ME, Reuter VE, Bander NH, Old LJ, Melamed MR.
Immunoanatomic distribution of blood group antigens in the human urinary tract. Influence of secretor status.
Lab Invest. 1986 Oct ;55(4):444-54
PMID: 2429066
14 Bara J, Gautier R, Daher N, Zaghouani H, Decaens C.
Monoclonal antibodies against oncofetal mucin M1 antigens associated with precancerous colonic mucosae.
Cancer Res. 1986 Aug ;46(8):3983-9
PMID: 3524800